A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
暂无分享，去创建一个
Suzanne F. Jones | G. Shapiro | S. Shreeve | A. Razak | J. Bendell | J. Infante | B. Houk | K. Pierce | L. Siu | P. Bedard | S. Pandya | Albiruni R. A. Razak | J. Cleary | W. Roberts | Johanna C. Bendell | S. Martin Shreeve